David Bennett to Treatment Outcome
This is a "connection" page, showing publications David Bennett has written about Treatment Outcome.
Connection Strength
0.178
-
Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease. J Alzheimers Dis. 2017; 55(3):1131-1139.
Score: 0.078
-
Discovery and Validation of Agonistic Angiotensin Receptor Autoantibodies as Biomarkers of Adverse Outcomes. Circulation. 2017 01 31; 135(5):449-459.
Score: 0.019
-
Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense?oligonucleotides. EMBO Mol Med. 2016 04 01; 8(4):328-45.
Score: 0.019
-
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer's disease. Alzheimers Res Ther. 2015; 7(1):51.
Score: 0.018
-
The influence of immediate knee flexion on blood loss and other parameters following total knee replacement. Bone Joint J. 2014 Feb; 96-B(2):201-9.
Score: 0.016
-
Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women. Neurology. 2014 Jan 21; 82(3):222-9.
Score: 0.016
-
Dopexamine and survival: areas of consistency. Anaesthesia. 2009 Nov; 64(11):1258; author reply 1259.
Score: 0.012